Literature DB >> 27365534

A tale of two sites: how inflammation can reshape the microbiomes of the gut and lungs.

Brittan S Scales1, Robert P Dickson1, Gary B Huffnagle2.   

Abstract

Inflammation can directly and indirectly modulate the bacterial composition of the microbiome. Although studies of inflammation primarily focus on its function to negatively select against potential pathogens, some bacterial species have the ability to exploit inflammatory byproducts for their benefit. Inflammatory cells release reactive nitrogen species as antimicrobial effectors against infection, but some facultative anaerobes can also utilize the increase in extracellular nitrate in their environment for anaerobic respiration and growth. This phenomenon has been studied in the gastrointestinal tract, where blooms of facultative anaerobic Gammaproteobacteria, primarily Escherichia coli, often occur during colonic inflammation. In cystic fibrosis, Pseudomonas aeruginosa, another Gammaproteobacteria facultative anaerobe, can reduce nitrogen for anaerobic respiration and it blooms in the airways of the chronically inflamed cystic fibrosis lung. This review focuses on the evidence that inflammation can provide terminal electron acceptors for anaerobic respiration and can support blooms of facultative anaerobes, such as E. coli and P. aeruginosa in distinct, but similar, environments of the inflamed gastrointestinal and respiratory tracts. © Society for Leukocyte Biology.

Entities:  

Keywords:  E. coli; P. aeruginosa; cystic fibrosis; inflammatory bowel disease; nitrate reduction

Mesh:

Substances:

Year:  2016        PMID: 27365534      PMCID: PMC5069096          DOI: 10.1189/jlb.3MR0316-106R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  80 in total

1.  A Toll-like receptor recognizes bacterial DNA.

Authors:  H Hemmi; O Takeuchi; T Kawai; T Kaisho; S Sato; H Sanjo; M Matsumoto; K Hoshino; H Wagner; K Takeda; S Akira
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

2.  Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis.

Authors:  Uri Gophna; Katrin Sommerfeld; Sharon Gophna; W Ford Doolittle; Sander J O Veldhuyzen van Zanten
Journal:  J Clin Microbiol       Date:  2006-09-20       Impact factor: 5.948

3.  Involvement of oxidative stress in bactericidal activity of 2-(2-nitrovinyl) furan against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus.

Authors:  T O Ajiboye; A M Naibi; I O Abdulazeez; I O Alege; A O Mohammed; S A Bello; I I Yusuf; O B Ibitoye; H F Muritala
Journal:  Microb Pathog       Date:  2015-12-02       Impact factor: 3.738

Review 4.  Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets.

Authors:  Daniel J Hassett; John Cuppoletti; Bruce Trapnell; Sergei V Lymar; John J Rowe; Sang Sun Yoon; George M Hilliard; Kislay Parvatiyar; Moneesha C Kamani; Daniel J Wozniak; Sung Hei Hwang; Timothy R McDermott; Urs A Ochsner
Journal:  Adv Drug Deliv Rev       Date:  2002-12-05       Impact factor: 15.470

5.  Synergy of nitric oxide and silver sulfadiazine against gram-negative, gram-positive, and antibiotic-resistant pathogens.

Authors:  Benjamin J Privett; Susan M Deupree; Christopher J Backlund; Kavitha S Rao; C Bryce Johnson; Peter N Coneski; Mark H Schoenfisch
Journal:  Mol Pharm       Date:  2010-11-11       Impact factor: 4.939

6.  Chronic obstructive pulmonary disease and asthma-associated Proteobacteria, but not commensal Prevotella spp., promote Toll-like receptor 2-independent lung inflammation and pathology.

Authors:  Jeppe M Larsen; Hanieh S Musavian; Tariq M Butt; Camilla Ingvorsen; Anna H Thysen; Susanne Brix
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

7.  Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis.

Authors:  M Kolpen; C R Hansen; T Bjarnsholt; C Moser; L D Christensen; M van Gennip; O Ciofu; L Mandsberg; A Kharazmi; G Döring; M Givskov; N Høiby; P Ø Jensen
Journal:  Thorax       Date:  2009-10-21       Impact factor: 9.139

8.  Antibacterial Action of Nitric Oxide-Releasing Chitosan Oligosaccharides against Pseudomonas aeruginosa under Aerobic and Anaerobic Conditions.

Authors:  Katelyn P Reighard; Mark H Schoenfisch
Journal:  Antimicrob Agents Chemother       Date:  2015-08-03       Impact factor: 5.191

9.  Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers.

Authors:  Lotta Krogius-Kurikka; Anna Lyra; Erja Malinen; Johannes Aarnikunnas; Jarno Tuimala; Lars Paulin; Harri Mäkivuokko; Kajsa Kajander; Airi Palva
Journal:  BMC Gastroenterol       Date:  2009-12-17       Impact factor: 3.067

10.  Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome.

Authors:  I M Carroll; T Ringel-Kulka; J P Siddle; Y Ringel
Journal:  Neurogastroenterol Motil       Date:  2012-02-20       Impact factor: 3.598

View more
  36 in total

Review 1.  Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health.

Authors:  Carl D Koch; Mark T Gladwin; Bruce A Freeman; Jon O Lundberg; Eddie Weitzberg; Alison Morris
Journal:  Free Radic Biol Med       Date:  2016-12-16       Impact factor: 7.376

Review 2.  Lung inflammation and disease: A perspective on microbial homeostasis and metabolism.

Authors:  Roberto Mendez; Sulagna Banerjee; Sanjoy K Bhattacharya; Santanu Banerjee
Journal:  IUBMB Life       Date:  2018-11-22       Impact factor: 3.885

Review 3.  The microbiome-metabolome crosstalk in the pathogenesis of respiratory fungal diseases.

Authors:  Samuel M Gonçalves; Katrien Lagrou; Cláudio Duarte-Oliveira; Johan A Maertens; Cristina Cunha; Agostinho Carvalho
Journal:  Virulence       Date:  2016-11-07       Impact factor: 5.882

4.  Inhalation Injury: Unmet Clinical Needs and Future Research.

Authors:  Kiran Dyamenahalli; Gaurav Garg; Jeffrey W Shupp; Paulius V Kuprys; Mashkoor A Choudhry; Elizabeth J Kovacs
Journal:  J Burn Care Res       Date:  2019-08-14       Impact factor: 1.845

Review 5.  The promise of the gut microbiome as part of individualized treatment strategies.

Authors:  Daniel A Schupack; Ruben A T Mars; Dayne H Voelker; Jithma P Abeykoon; Purna C Kashyap
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-08-27       Impact factor: 46.802

6.  The Metabolic Adaptation in Response to Nitrate Is Critical for Actinobacillus pleuropneumoniae Growth and Pathogenicity under the Regulation of NarQ/P.

Authors:  Qiuhong Zhang; Hao Tang; Chaoyue Yan; Weiyao Han; Lu Peng; Jiajia Xu; Xiabing Chen; Paul R Langford; Weicheng Bei; Qi Huang; Rui Zhou; Lu Li
Journal:  Infect Immun       Date:  2022-08-08       Impact factor: 3.609

Review 7.  The respiratory tract microbiome and lung inflammation: a two-way street.

Authors:  G B Huffnagle; R P Dickson; N W Lukacs
Journal:  Mucosal Immunol       Date:  2016-12-14       Impact factor: 7.313

8.  Meta-analysis Reveals Potential Influence of Oxidative Stress on the Airway Microbiomes of Cystic Fibrosis Patients.

Authors:  Xing Shi; Zhancheng Gao; Qiang Lin; Liping Zhao; Qin Ma; Yu Kang; Jun Yu
Journal:  Genomics Proteomics Bioinformatics       Date:  2020-03-12       Impact factor: 7.691

9.  Lung and gut microbiota are altered by hyperoxia and contribute to oxygen-induced lung injury in mice.

Authors:  Shanna L Ashley; Michael W Sjoding; Antonia P Popova; Tracy X Cui; Matthew J Hoostal; Thomas M Schmidt; William R Branton; Michael G Dieterle; Nicole R Falkowski; Jennifer M Baker; Kevin J Hinkle; Kristine E Konopka; John R Erb-Downward; Gary B Huffnagle; Robert P Dickson
Journal:  Sci Transl Med       Date:  2020-08-12       Impact factor: 17.956

10.  Pharyngeal Microbial Signatures Are Predictive of the Risk of Fungal Pneumonia in Hematologic Patients.

Authors:  Claudio Costantini; Emilia Nunzi; Angelica Spolzino; Melissa Palmieri; Giorgia Renga; Teresa Zelante; Lukas Englmaier; Katerina Coufalikova; Zdeněk Spáčil; Monica Borghi; Marina M Bellet; Enzo Acerbi; Matteo Puccetti; Stefano Giovagnoli; Roberta Spaccapelo; Vincenzo N Talesa; Giuseppe Lomurno; Francesco Merli; Luca Facchini; Antonio Spadea; Lorella Melillo; Katia Codeluppi; Francesco Marchesi; Gessica Marchesini; Daniela Valente; Giulia Dragonetti; Gianpaolo Nadali; Livio Pagano; Franco Aversa; Luigina Romani
Journal:  Infect Immun       Date:  2021-07-15       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.